Definitive Healthcare Corp (DH)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Definitive Healthcare Corp. (DH) Q3 2025 Earnings Call Transcript
Definitive Healthcare Corp. ( DH ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Jonathan Paris - Chief Legal Officer & Secretary Kevin Coop - CEO & Director Casey Heller - Chief Financial Officer Conference Call Participants Jared Haase - William Blair & Company L.L.C., Research Division Nishad Patwardhan - Goldman Sachs Group, Inc., Research Division Johnathan McCary - Raymond James & Associates, Inc., Research Division Jenny Shen - BTIG, LLC, Research Division David Grossman - Stifel, Nicolaus & Company, Incorporated, Research Division Presentation Operator Welcome to Definitive Healthcare's Q3 2025 Earnings Call.
Definitive Healthcare Corp. (DH) Beats Q3 Earnings and Revenue Estimates
Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.1 per share a year ago.
What Makes Definitive Healthcare (DH) a New Buy Stock
Definitive Healthcare (DH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Definitive Healthcare Corp. (DH) Q2 2025 Earnings Call Transcript
Definitive Healthcare Corp. (NASDAQ:DH ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Casey Heller - Chief Financial Officer Jonathan Paris - Chief Legal Officer Kevin D. Coop - CEO & Director Conference Call Participants David Michael Grossman - Stifel, Nicolaus & Company, Incorporated, Research Division George Robert Hill - Deutsche Bank AG, Research Division Johnathan M.
Definitive Healthcare Corp. (DH) Q2 Earnings and Revenues Top Estimates
Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.09 per share a year ago.
Definitive Healthcare Corp. (DH) Q1 2025 Earnings Call Transcript
Definitive Healthcare Corp. (NASDAQ:DH ) Q1 2025 - Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Matthew Ruderman - Investor Relations Kevin Coop - CEO Rick Booth - CFO Casey Heller - SVP, Finance Conference Call Participants Jared Haase - William Blair Craig Hettenbach - Morgan Stanley David Grossman - Stifel George Hill - Deutsche Bank Jenny Shen - BTIG Operator Welcome to Definitive Healthcare's Q1 2025 Earnings Call. Later, we will conduct a question and answer session.
Definitive Healthcare Corp. (DH) Beats Q1 Earnings and Revenue Estimates
Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.08 per share a year ago.
Definitive Healthcare Corp. (DH) Q4 2024 Earnings Call Transcript
Definitive Healthcare Corp. (NASDAQ:DH ) Q4 2024 Results Conference Call February 27, 2025 5:00 PM ET Company Participants Matthew Ruderman - Investor Relations Kevin Coop - Chief Executive Officer Rick Booth - Chief Financial Officer Conference Call Participants Jared Haase - William Blair Hanna Lee - Bank of America Jenny Shen - BTIG David Grossman - Stifel Maxi Ma - Deutsche Bank Johnathan McCary - Raymond James Craig Hettenbach - Morgan Stanley Jeff Garro - Stephens Operator Welcome to Definitive Healthcare's Q4 2024 Earnings Call. [Operator Instructions] I would like to now turn the call over to your host.
Definitive Healthcare Corp. (DH) Q4 Earnings and Revenues Surpass Estimates
Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.07 per share a year ago.
A Dive Into Definitive Healthcare
Definitive Healthcare trades at a discount to the overall market based on P/E, and a new CEO with a focus on simplifying operations but faces declining profits and revenues. The company also has recently announced a new $100 billion stock buyback authorization and is seeing significant unlevered free cash flow. A first look at Definitive Healthcare follows in the paragraphs below.
Definitive Healthcare (DH) Surges 8.4%: Is This an Indication of Further Gains?
Definitive Healthcare (DH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Definitive Healthcare (DH) Moves to Buy: Rationale Behind the Upgrade
Definitive Healthcare (DH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
